AF
DVAX

Amalgamated Financial’s Dynavax Technologies DVAX Stock Holding History

Amalgamated Financial’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$191K Buy
+17,581
New +$214K ﹤0.01% 1914

Other funds holding DVAX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return

Amalgamated Financial's DVAX Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Dynavax Technologies (DVAX) in Q1 2022: 17,581 shares worth $191K. The stake represents ﹤0.01% of the portfolio and ranks #1914 among its holdings.

207 funds tracked by Wall St. Rank hold DVAX as of Q1 2022.

  • Amalgamated Financial held 17,581 shares of Dynavax Technologies worth $191K as of Q1 2022.
  • Dynavax Technologies was a new Amalgamated Financial position in Q1 2022.
  • Dynavax Technologies made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #1914 holding.
  • 207 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.